Aurelie Garant, MD

Simulation-omitted prostate SBRT (SO-PRO) has potential to reduce treatment delays and expand access to care but presents unique challenges for SBRT workflows that require careful management of target and organ-at-risk (OAR) dose. A major barrier is diagnosti...